LEP and breast cancer: The data in the current study suggest that leptin may up-regulate ObR to activate the P38/MAPK and MAPK/ERK 1/2 signaling pathways, which in turn stimulate IL-8 promoter and IL-8 production in M2 macrophages, consequently promoting breast cancer progression (Figure 8).